### 53175 Federal Register / Vol. 79, No. 173 / Monday, September 8, 2014 / Notices

1450; by fax marked to her attention at (571) 273–7755; or by email to Mary.Till@uspto.gov.

**SUPPLEMENTARY INFORMATION :**  Section 156 of Title 35, United States Code, generally provides that the term of a patent may be extended for a period of up to five years if the patent claims a product, or a method of making or using a product, that has been subject to certain defined regulatory review, and that the patent may be extended for interim periods of up to one year if the regulatory review is anticipated to extend beyond the expiration date of the patent.

On May 13, 2014, Bracco Suisse SA, the patent owner of record, timely filed an application under 35 U.S.C. § 156(d)(5) for an interim extension of the term of U.S. Patent No. 5,686,060. The patent claims the human drug product LUMASON TM , sulfur hexafluoride microbubbles. The application indicates that Bracco Diagnostics Inc., an affiliate of patent owner Bracco Suisse SA, initially submitted a New Drug Application (NDA) #21–315 to the Food and Drug Administration (FDA) on January 21, 2001, and withdrew NDA #21–315 on December 20, 2007. Bracco Diagnostics Inc. submitted a new NDA #203–684 on December 20, 2011. FDA accepted NDA 203–684 for filing on February 19, 2012.

Review of the application indicates that, except for permission to market or use the product commercially, the subject patent would be eligible for an extension of the patent term under 35 U.S.C. 156, and that the patent should be extended for one year as required by 35 U.S.C. 156(d)(5)(B). Because the regulatory review period will continue beyond the original expiration date of the patent, November 11, 2014, interim extension of the patent term under 35 U.S.C. 156(d)(5) is appropriate.

An interim extension under 35 U.S.C. 156(d)(5) of the term of U.S. Patent No. 5,686,060 is granted for a period of one year from the original expiration date of the patent.

Dated: August 26, 2014.

Andrew Hirshfeld. Deputy Commissioner for Patent Examination Policy, United States Patent and Trademark Office.
[FR Doc. 2014–21308 Filed 9–5–14; 8:45 am]

**BILLING CODE 3510–16–P COMMODITY FUTURES TRADING**  **COMMISSION**

**Sunshine Act Meetings**

**TIME AND DATE :**  10:30 a.m., Thursday, September 11, 2014.

**PLACE :**  1155 21st St. NW., Washington, DC, 9th Floor Commission Conference Room.

**STATUS :**  Closed.

**MATTERS TO BE CONSIDERED :**  Surveillance, Enforcement Matters, and Examinations. In the event that the times, dates, or locations of this or any future meetings change, an announcement of the change, along with the new time and place of the meeting will be posted on the Commission’s Web site at http://www.cftc.gov.

**CONTACT PERSON FOR MORE INFORMATION :**  Christopher J. Kirkpatrick, 202–418–
5964.
Christopher J. Kirkpatrick, Secretary of the Commission. [FR Doc. 2014–21400 Filed 9–4–14; 4:15 pm]

**BILLING CODE 6351–01–P**

**DEPARTMENT OF DEFENSE**

**Department of the Army**

**Army Education Advisory Committee Meeting Notice** 

**AGENCY :**  Department of the Army, DoD.

**ACTION :**  Notice of open committee meeting.

**SUMMARY :**  The Department of the Army is publishing this notice to announce the following Federal advisory committee meeting of the Army Education Advisory Committee. This meeting is open to the public.

**DATES :**  The Army Education Advisory Committee will meet from 8:00 a.m. to 5:00 p.m. on October 8 and 9, 2014 and from 8:00 a.m. to 2:00 p.m. on October 10, 2014.

**ADDRESSES :**  Army Education Advisory Committee, U.S. Training Doctrine Command, Building 950, Conference Room 2014, Fort Eustis, VA 23604.

**FOR FURTHER INFORMATION CONTACT :**  Mr. Wayne Joyner, the Designated Federal Officer for the committee, in writing at ATTN: ATTG–ZC, U.S. Training Doctrine Command, 950 Jefferson Ave, Fort Eustis, VA 23604, by email at albert.w.joyner.civ@mail.mil, or by telephone at (757) 501–5810.

**SUPPLEMENTARY INFORMATION :**  The committee meeting is being held under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.150.

Purpose of the Meeting: The purpose of the meeting is to collect and analyze corporate and academia best practices for dealing with sexual harassment and assault.

Proposed Agenda: October 8–9: The committee is chartered to provide independent advice and recommendations to the Secretary of the Army on the educational, doctrinal, and research policies and activities of U.S. Army educational programs. The committee will review and evaluate information related to dealing with sexual harassment and assault, and explore cultural issues affecting sexual harassment and assault. The committee will discuss societal norms, generational differences, changes in cultural dynamics, and sexual attitudes that may impact the Army’s culture.

Public Accessibility to the Meeting: Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102–3.140 through 102– 3.165, and subject to the availability of space, this meeting is open to the public. Seating is on a first to arrive basis. Attendees are requested to submit their name, affiliation, and daytime phone number seven business days prior to the meeting to Mr. Joyner, via electronic mail, the preferred mode of submission, at the address listed in the

**FOR FURTHER INFORMATION CONTACT** section.

Because the meeting of the committee will be held in a Federal Government facility on a military base, security screening is required. A photo ID is required to enter base. Please note that security and gate guards have the right to inspect vehicles and persons seeking to enter and exit the installation. U.S. Training Doctrine Command is fully handicap accessible. Wheelchair access is available in front at the main entrance of the building. For additional information about public access procedures, contact Mr. Joyner, the committee’s Designated Federal Officer, at the email address or telephone number listed in the **FOR FURTHER**
**INFORMATION CONTACT** section.

Written Comments or Statements: Pursuant to 41 CFR 102–3.105(j) and 102–3.140 and section 10(a)(3) of the Federal Advisory Committee Act, the public or interested organizations may submit written comments or statements to the committee, in response to the stated agenda of the open meeting or in regard to the committee’s mission in general. Written comments or statements should be submitted to Mr. Joyner the committee Designated